Skip to main content
. Author manuscript; available in PMC: 2011 Sep 1.
Published in final edited form as: Urology. 2010 Apr 15;76(3):695–700. doi: 10.1016/j.urology.2009.12.073

Figure 1.

Figure 1

Figure 1

Figure 1

(a) Actuarial 10-year Kaplan-Meier estimates of biochemical recurrence rates of men who were candidates for active surveillance. (b) Actuarial 10-year Kaplan- Meier estimates of biochemical recurrence rates of men who were candidates for active surveillance with the lowest risk of progression, defined by age <60, not obese, and no Agent Orange exposure. (c) Actuarial 10-year Kaplan-Meier estimates of biochemical recurrence rates of men who were candidates for active surveillance with the lowest risk of progression, defined by age <60, not obese, and no Agent Orange exposure, stratified by age (log-rank, p=0.003).